This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002 Oct;15(4):716–46.Brown-ElliottBAWallaceRJClinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria2002Oct15471646Search in Google Scholar
Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020 Jun 17;27(1):74.GopalaswamyRShanmugamSMondalRSubbianSOf tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment2020Jun1727174Search in Google Scholar
Wassilew N, Hoffmann H, Andrejak C, Lange C. Pulmonary Disease Caused by Non-Tuberculous Mycobacteria. Respir Int Rev Thorac Dis. 2016;91(5):386–402.WassilewNHoffmannHAndrejakCLangeCPulmonary Disease Caused by Non-Tuberculous Mycobacteria2016915386402Search in Google Scholar
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis. 2020 Aug 14;71(4):905–13.DaleyCLIaccarinoJMLangeCCambauEWallaceRJJrAndrejakCTreatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline2020Aug1471490513Search in Google Scholar
Griffith DE, Daley CL. Treatment of Mycobacterium abscessus Pulmonary Disease. Chest. 2022 Jan;161(1):64–75.GriffithDEDaleyCLTreatment of Mycobacterium abscessus Pulmonary Disease2022Jan16116475Search in Google Scholar
Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020 Sep;152(3):185.SharmaSKUpadhyayVEpidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases2020Sep1523185Search in Google Scholar
Ratnatunga CN, Lutzky VP, Kupz A, Doolan DL, Reid DW, Field M, et al. The Rise of Non-Tuberculosis Mycobacterial Lung Disease. Front Immunol [Internet]. 2020 [cited 2023 Oct 15];11. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2020.00303RatnatungaCNLutzkyVPKupzADoolanDLReidDWFieldMThe Rise of Non-Tuberculosis Mycobacterial Lung Disease[Internet]. 2020 [cited 2023 Oct 15];11. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2020.00303Search in Google Scholar
Diel R, Jacob J, Lampenius N, Loebinger M, Nienhaus A, Rabe KF, et al. Burden of non-tuberculous mycobacterial pulmonary disease in Germany. Eur Respir J. 2017 Apr;49(4):1602109.DielRJacobJLampeniusNLoebingerMNienhausARabeKFBurden of non-tuberculous mycobacterial pulmonary disease in Germany2017Apr4941602109Search in Google Scholar
Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous Pulmonary Mycobacteriosis in Denmark. Am J Respir Crit Care Med. 2010 Mar;181(5):514–21.AndréjakCThomsenVØJohansenISRiisABenfieldTLDuhautPNontuberculous Pulmonary Mycobacteriosis in Denmark2010Mar181551421Search in Google Scholar
Przybylski G, Bukowski J, Kowalska W, Pilaczyńska-Cemel M, Krawiecka D. Trends from the Last Decade with Nontuberculous Mycobacteria Lung Disease (NTM-LD): Clinicians’ Perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland. Pathogens. 2023 Jul 28;12(8):988.PrzybylskiGBukowskiJKowalskaWPilaczyńska-CemelMKrawieckaDTrends from the Last Decade with Nontuberculous Mycobacteria Lung Disease (NTM-LD): Clinicians’ Perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland2023Jul28128988Search in Google Scholar
Lee MR, Sheng WH, Hung CC, Yu CJ, Lee LN, Hsueh PR. Mycobacterium abscessus Complex Infections in Humans. Emerg Infect Dis. 2015 Sep;21(9):1638–46.LeeMRShengWHHungCCYuCJLeeLNHsuehPRMycobacterium abscessus Complex Infections in Humans2015Sep219163846Search in Google Scholar
Moore M, Frerichs JB. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. J Invest Dermatol. 1953 Feb;20(2):133–69.MooreMFrerichsJBAn unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp1953Feb20213369Search in Google Scholar
Medjahed H, Gaillard JL, Reyrat JM. Mycobacterium abscessus: a new player in the mycobacterial field. Trends Microbiol. 2010 Mar 1;18(3):117–23.MedjahedHGaillardJLReyratJMMycobacterium abscessus: a new player in the mycobacterial field2010Mar118311723Search in Google Scholar
Boudehen YM, Kremer L. Mycobacterium abscessus. Trends Microbiol. 2021 Oct 1;29(10):951–2.BoudehenYMKremerLMycobacterium abscessus2021Oct129109512Search in Google Scholar
Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother. 2012 Apr;67(4):810–8.NessarRCambauEReyratJMMurrayAGicquelBMycobacterium abscessus: a new antibiotic nightmare2012Apr6748108Search in Google Scholar
Parmar S, Tocheva EI. The cell envelope of Mycobacterium abscessus and its role in pathogenesis. PLOS Pathog. 2023 5;19(5):e1011318.ParmarSTochevaEIThe cell envelope of Mycobacterium abscessus and its role in pathogenesis20235195e1011318Search in Google Scholar
Roux AL, Viljoen A, Bah A, Simeone R, Bernut A, Laencina L, et al. The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biol. 2016 Nov;6(11): 160185.RouxALViljoenABahASimeoneRBernutALaencinaLThe distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages2016Nov611160185Search in Google Scholar
Jönsson B, Ridell M, Wold AE. Phagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells. APMIS. 2013;121(1):45–55.JönssonBRidellMWoldAEPhagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells201312114555Search in Google Scholar
Rüger K, Hampel A, Billig S, Rücker N, Suerbaum S, Bange FC. Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens. J Clin Microbiol. 2014 Jan;52(1):244–50.RügerKHampelABilligSRückerNSuerbaumSBangeFCCharacterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens2014Jan52124450Search in Google Scholar
Degiacomi G, Sammartino JC, Chiarelli LR, Riabova O, Makarov V, Pasca MR. Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. Int J Mol Sci. 2019 Nov 22;20(23):5868.DegiacomiGSammartinoJCChiarelliLRRiabovaOMakarovVPascaMRMycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients2019Nov2220235868Search in Google Scholar
Harris KA, Kenna DTD. Mycobacterium abscessus infection in cystic fibrosis: molecular typing and clinical outcomes. J Med Microbiol. 2014;63(10):1241–6.HarrisKAKennaDTDMycobacterium abscessus infection in cystic fibrosis: molecular typing and clinical outcomes2014631012416Search in Google Scholar
López-Valdez JA, Aguilar-Alonso LA, Gándara-Quezada V, Ruiz-Rico GE, Ávila-Soledad JM, Reyes AA, et al. Cystic fibrosis: current concepts. Bol Méd Hosp Infant México [Internet]. 2021 [cited 2023 Sep 27];78(6). Available from: https://www.bmhim.com/frame_esp.php?id=279López-ValdezJAAguilar-AlonsoLAGándara-QuezadaVRuiz-RicoGEÁvila-SoledadJMReyesAACystic fibrosis: current concepts[Internet]. 2021 [cited 2023 Sep 27];78(6). Available from: https://www.bmhim.com/frame_esp.php?id=279Search in Google Scholar
Recchia D, Stelitano G, Stamilla A, Gutierrez DL, Degiacomi G, Chiarelli LR, et al. Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options. Int J Mol Sci. 2023 Feb 27;24(5):4635.RecchiaDStelitanoGStamillaAGutierrezDLDegiacomiGChiarelliLRMycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options2023Feb272454635Search in Google Scholar
Gulani A, Weiler T. Genetics, Autosomal Recessive. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Nov 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK546620/GulaniAWeilerTGenetics, Autosomal RecessiveIn:Treasure Island (FL)StatPearls Publishing2023[cited 2023 Nov 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK546620/Search in Google Scholar
Yu E, Sharma S. Cystic Fibrosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Sep 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK493206/YuESharmaSCystic FibrosisIn:Treasure Island (FL)StatPearls Publishing2023[cited 2023 Sep 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK493206/Search in Google Scholar
Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020 Jan;8(1):65–124.BellSCMallMAGutierrezHMacekMMadgeSDaviesJCThe future of cystic fibrosis care: a global perspective2020Jan8165124Search in Google Scholar
Cystic Fibrosis in Children | Symptoms, Diagnosis & Treatment [Internet]. [cited 2023 Oct 16]. Available from: https://www.cincinnatichildrens.org/health/c/cystic-fibrosis[cited 2023 Oct 16]. Available from: https://www.cincinnatichildrens.org/health/c/cystic-fibrosisSearch in Google Scholar
VanDevanter DR, Kahle JS, O’Sullivan AK, Sikirica S, Hodgkins PS. Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment. J Cyst Fibros. 2016 Mar 1;15(2):147–57.VanDevanterDRKahleJSO’SullivanAKSikiricaSHodgkinsPSCystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment2016Mar115214757Search in Google Scholar
Surette MG. The Cystic Fibrosis Lung Microbiome. Ann Am Thorac Soc. 2014 Jan;11(Supplement 1):S61–5.SuretteMGThe Cystic Fibrosis Lung Microbiome2014Jan11Supplement 1S615Search in Google Scholar
Brugha R, Spencer H. Mycobacterium abscessus in cystic fibrosis. Science. 2021 Apr 30;372(6541): 465–6.BrughaRSpencerHMycobacterium abscessus in cystic fibrosis2021Apr3037265414656Search in Google Scholar
Olivier KN, Weber DJ, Wallace RJ, Faiz AR, Lee JH, Zhang Y, et al. Nontuberculous Mycobacteria. Am J Respir Crit Care Med. 2003 Mar 15;167(6):828–34.OlivierKNWeberDJWallaceRJFaizARLeeJHZhangYNontuberculous Mycobacteria2003Mar15167682834Search in Google Scholar
Richard M, Gutiérrez AV, Kremer L. Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e01879–19.RichardMGutiérrezAVKremerLDissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus2020Jan27642e0187919Search in Google Scholar
Scotet V, L’Hostis C, Férec C. The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes. 2020 May 26;11(6):589.ScotetVL’HostisCFérecCThe Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery2020May26116589Search in Google Scholar
Daley CL, Winthrop KL. Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management. J Infect Dis. 2020 Sep 15;222(Suppl 4):S199–211.DaleyCLWinthropKLMycobacterium avium Complex: Addressing Gaps in Diagnosis and Management2020Sep15222Suppl 4S199211Search in Google Scholar
Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017 Nov;72(Suppl 2):ii1–64.HaworthCSBanksJCapstickTFisherAJGorsuchTLaurensonIFBritish Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)2017Nov72Suppl 2ii164Search in Google Scholar
Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017 Nov 1;72(Suppl 2):ii1–64.HaworthCSBanksJCapstickTFisherAJGorsuchTLaurensonIFBritish Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)2017Nov172Suppl 2ii164Search in Google Scholar
Rose SJ, Neville ME, Gupta R, Bermudez LE. Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection. PloS One. 2014;9(9):e108703.RoseSJNevilleMEGuptaRBermudezLEDelivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection201499e108703Search in Google Scholar
Kang N, Jeon K, Kim H, Kwon OJ, Huh HJ, Lee NY, et al. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease. Chest. 2021 Aug 1;160(2):436–45.KangNJeonKKimHKwonOJHuhHJLeeNYOutcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease2021Aug1160243645Search in Google Scholar
Rominski A, Selchow P, Becker K, Brülle JK, Dal Molin M, Sander P. Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes. J Antimicrob Chemother. 2017 Aug 1;72(8):2191–200.RominskiASelchowPBeckerKBrülleJKDal MolinMSanderPElucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes2017Aug17282191200Search in Google Scholar
Caballero AR, Marquart ME, O’Callaghan RJ, Thibodeaux BA, Johnston KH, Dajcs JJ. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo. Curr Eye Res. 2006 Jan; 31(1):23–9.CaballeroARMarquartMEO’CallaghanRJThibodeauxBAJohnstonKHDajcsJJEffectiveness of fluoroquinolones against Mycobacterium abscessus in vivo2006Jan311239Search in Google Scholar
Jafri HS, McCracken GH. Fluoroquinolones in Paediatrics. Drugs. 1999 Oct 1;58(2):43–8.JafriHSMcCrackenGHFluoroquinolones in Paediatrics1999Oct1582438Search in Google Scholar
Sabin AP, Ferrieri P, Kline S. Mycobacterium abscessus Complex Infections in Children: A Review. Curr Infect Dis Rep. 2017 Nov;19:46.SabinAPFerrieriPKlineSMycobacterium abscessus Complex Infections in Children: A Review2017Nov1946Search in Google Scholar
Anderson MW, Schrijver I. Next Generation DNA Sequencing and the Future of Genomic Medicine. Genes. 2010 May 25;1(1):38–69.AndersonMWSchrijverINext Generation DNA Sequencing and the Future of Genomic Medicine2010May25113869Search in Google Scholar
Gasperskaja E, Kučinskas V. The most common technologies and tools for functional genome analysis. Acta Medica Litu. 2017;24(1):1–11.GasperskajaEKučinskasVThe most common technologies and tools for functional genome analysis2017241111Search in Google Scholar
Gautam SS, KC R, Leong KW, Mac Aogáin M, O’Toole RF. A step-by-step beginner’s protocol for whole genome sequencing of human bacterial pathogens. J Biol Methods. 2019 Mar 15;6(1):e110.GautamSSKCRLeongKWMac AogáinMO’TooleRFA step-by-step beginner’s protocol for whole genome sequencing of human bacterial pathogens2019Mar1561e110Search in Google Scholar
Lewin A, Kamal E, Semmler T, Winter K, Kaiser S, Schäfer H, et al. Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients. Virulence. 2021 Dec 31;12(1):2415–29.LewinAKamalESemmlerTWinterKKaiserSSchäferHGenetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients2021Dec31121241529Search in Google Scholar
Austin-Tse CA, Jobanputra V, Perry DL, Bick D, Taft RJ, Venner E, et al. Best practices for the interpretation and reporting of clinical whole genome sequencing. Npj Genomic Med. 2022 Apr 8;7(1):1–13.Austin-TseCAJobanputraVPerryDLBickDTaftRJVennerEBest practices for the interpretation and reporting of clinical whole genome sequencing2022Apr871113Search in Google Scholar
Dohal M, Porvaznik I, Kusnir P, Mokry J. Whole-Genome Sequencing in Relation to Resistance of. Acta Medica Martiniana. 2019 Apr 1;19(1):12–21.DohalMPorvaznikIKusnirPMokryJWhole-Genome Sequencing in Relation to Resistance of2019Apr11911221Search in Google Scholar
Pinto ACSM, De Pierri CR, Evangelista AG, Gomes AS de LPB, Luciano FB. Deoxynivalenol: Toxicology, Degradation by Bacteria, and Phylogenetic Analysis. Toxins. 2022 Feb;14(2):90.PintoACSMDe PierriCREvangelistaAGGomes AS deLPBLucianoFBDeoxynivalenol: Toxicology, Degradation by Bacteria, and Phylogenetic Analysis2022Feb14290Search in Google Scholar
Hatherell HA, Colijn C, Stagg HR, Jackson C, Winter JR, Abubakar I. Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review. BMC Med. 2016 Mar 23;14:21.HatherellHAColijnCStaggHRJacksonCWinterJRAbubakarIInterpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review2016Mar231421Search in Google Scholar
Köser CU, Ellington MJ, Peacock SJ. Whole-genome sequencing to control antimicrobial resistance. Trends Genet. 2014 Sep 1;30(9):401–7.KöserCUEllingtonMJPeacockSJWhole-genome sequencing to control antimicrobial resistance2014Sep13094017Search in Google Scholar
Parcell BJ, Gillespie SH, Pettigrew KA, Holden MTG. Clinical perspectives in integrating whole-genome sequencing into the investigation of healthcare and public health outbreaks – hype or help? J Hosp Infect. 2021 Mar;109:1–9.ParcellBJGillespieSHPettigrewKAHoldenMTGClinical perspectives in integrating whole-genome sequencing into the investigation of healthcare and public health outbreaks – hype or help?2021Mar10919Search in Google Scholar
Dohal M, Porvaznik I, Solovic I, Mokry J. Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections. Microorganisms. 2021 Oct 27;9(11):2237.DohalMPorvaznikISolovicIMokryJWhole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections2021Oct279112237Search in Google Scholar